Article Details

ENHERTU® (fam-trastuzumab deruxtecan-nxki) significantly improved progression-free survival in ...

Retrieved on: 2021-08-09 13:07:30

Tags for this article:

Click the tags to see associated articles and topics

ENHERTU® (fam-trastuzumab deruxtecan-nxki) significantly improved progression-free survival in .... View article details on hiswai:

Excerpt

... the AstraZeneca and Daiichi Sankyo Company, Limited (Daiichi Sankyo) HER2-directed antibody drug conjugate (ADC), demonstrated superiority ...

Article found on: finance.yahoo.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up